Medical Oncology Dr. Orçun Can
✓ Medically verified profile Medical Oncology
Dr. Orçun Can
✓ Medically verified profile 17+ years experienceLanguages: Turkish, EnglishOnline consultation
★★★★★ From 2,400+ verified Acibadem patient reviews
Profile
About Dr. Orçun Can
Quick answer
Dr. Orçun Can is a Medical Oncology specialist at Acibadem Maslak Hospital in İstanbul with 17+ years of experience.
He treats metastatic non-clear cell renal cell carcinoma, metastatic and favorable-risk renal cell carcinoma, prostate cancer, early-stage breast cancer, advanced and refractory desmoid tumors, stage III cervical cancer, and limited-stage small-cell lung cancer, and provides adjuvant chemotherapy, concurrent chemoradiation, nivolumab therapy, tyrosine kinase inhibitor therapy, and imatinib therapy. He consults in Turkish and…
M.D. Orçun Can is a medical oncologist trained at Okmeydanı Training and Research Hospital, where he completed his specialty training in 2018. He has been practicing with Acıbadem Health Group since 2023, providing evidence-based cancer care and participating in multidisciplinary treatment planning.
He is an active member of leading professional societies, including the Turkish Society of Medical Oncology (TTOD), the European Society for Medical Oncology (ESMO), and the American Society of Clinical Oncology (ASCO). These memberships reflect his commitment to staying current with international advances in oncology and to delivering high-quality, patient-centered care.
Clinical Focus
Areas of Expertise
Conditions treated and procedures performed by this specialist.
Metastatic non-clear cell renal cell carcinomaMetastatic renal cell carcinomaFavorable-risk renal cell carcinomaProstate cancerEarly-stage breast cancerAdvanced and refractory desmoid tumorsStage III cervical cancerLimited-stage small-cell lung cancerAdjuvant chemotherapyConcurrent chemoradiationNivolumab therapyTyrosine kinase inhibitor therapyImatinib therapy
Background
Education
- 2018Okmeydanı Training and Research Hospital Medical Oncology
- 2014Medeniyet University Göztepe Training and Research Hospital Internal Medicine
- 2009Cukurova University Faculty of Medicine
Career
Professional Experience
- 2023Acibadem Health Group
- 2018–2021Istanbul Prof. Dr. Cemil Tascioglu City Hospital / Medical Oncology / Specialist Doctor
- 2018Nevşehir State Hospital / Medical Oncology / Specialist Doctor
- 2015–2018Istanbul Okmeydanı Training and Research Hospital / Assistant
- 2014–2015Kirklareli Pinarhisar State Hospital / Internal Medicine / Specialist Doctor
- 2009Mersin Tarsus Çiçekli Health Center / General Practitioner
Affiliations
Professional Memberships
- TTOD (Turkish Society of Medical Oncology)
- ESMO (European Society for Medical Oncology)
- ASCO (American Society of Clinical Oncology)
Research
Selected Publications
- Clinical Features and Prognostic Factors of Metastatic Non-Clear Cell Renal Cell Carcinoma: A Multicenter Study from the Turkish Oncology Group Kidney Cancer Consortium Urologia Internationalis, 107(6), 595-601., Doi: 10.1159/000528994 (Publication No: 8436265) (2023) EROL CİHAN, YEKEDUZ EMRE, TURAL DENİZ, KARAKAYA SERDAR, ŞENTÜRK ÖZTAŞ NİHAN, UÇAR GÖKHAN, KILIÇKAP SADETTİN, ERTÜRK İSMAİL, SEVER ÖZLEM NURAY, ARSL
- External Validation of a Novel Risk Model in Patients With Favorable Risk Renal Cell Carcinoma Defined by International Metastatic Renal Cell Carcinoma Database Consortium (IMDC): Results From the Turkish Oncology Group Kidney Cancer Consortium (TKCC) Database Clinical Genitourinary Cancer, 21(1), 175-182., Doi: 10.1016/j.clgc.2022.07.006 (Publication No: 8124532) (2023) YEKEDÜZ EMRE, KARAKAYA SERDAR, ERTÜRK İSMAİL, TURAL DENİZ, UÇAR GÖKHAN, ŞENTÜRK ÖZTAŞ NİHAN, ARIKAN RUKİYE, HIZAL MUTLU, KÜÇÜKARDA AHMET, SEVER ÖZL
- How reliable is the high-volume definition in prostate cancer patients: the potential game-changing role of PSMA Nuclear Medicine Communications, 44(9), 816-824., Doi: 10.1097/MNM.0000000000001722 (Publication No: 8436253 (2023)) GÜVEN OSMAN, KARYAĞAR SAVAŞ, ARICI SERDAR, ÖZÜLKER TAMER, CAN ORÇUN
- Serum fetuin-A and RANKL levels in patients with early stage breast cancer Journal of Medical Biochemistry, 42(2), 249-257., Doi: 10.5937/jomb0-37386 (Publication No: 8436129) (2023) AVŞAR USUL ÇİĞDEM, ARAL HALE, CAN ORÇUN, CAN TRABLUS DİDEM, KARAÇETİN DİDEM, NAZLI MEHMET ALİ, GÜRSU RIZA UMAR, KARABULUT SENEM
- Efficacy of Imatinib on Advanced and Refractory Desmoid Tumors: A Retrospective Study. Journal of Oncological Sciences (JOS), 8(2), 63-68., Doi: 10.37047/jos.2021-87391 (Control No: 8214846) (2022) ATCI MUHAMMED MUSTAFA, CAN ORÇUN, SEÇMELER ŞABAN, SAKİN ABDULLAH, AY ERSOY SEVAL, CİHAN ŞENER, SELVİ OĞUZHAN, GEREDELİ ÇAĞLAYAN
- The relationship between pan-immune-inflammation value and survival outcomes in patients with metastatic renal cell carcinoma treated with nivolumab i in the second line and beyond: a Turkish oncology group kidney cancer consortium (TKCC) study Journal of Cancer Research and Clinical Oncology, 148(12), 3537-3546., Doi: 10.1007/s00432-022-04055-5 (Publication No: 7696517) (2022) YEKEDÜZ EMRE, TURAL DENİZ, ERTÜRK İSMAİL, KARAKAYA SERDAR, EROL CİHAN, ERCELEP ÖZLEM, ARSLAN ÇAĞATAY, SEVER ÖZLEM NURAY, KILIÇKAP SAADETTİN, ŞENTÜR
- The relationship between systemic immune inflammation index and survival in patients with metastatic renal cell carcinomatreated withtyrosine kinase inhibitors. Scientific Reports, 12(1), 1-9., Doi: 10.1038/s41598-022-20056-3 (Publication No: 7307182) (2022) BİR YÜCEL KADRİYE, YEKEDÜZ EMRE, KARAKAYA SERDAR, TURAL DENİZ, ERTÜRK İSMAİL, EROL CİHAN, ERCELEP ÖZLEM, ŞENTÜRK ÖZTAŞ NİHAN, ARSLAN ÇAĞATAY, UÇAR
- Efect of Adjuvant Chemotherapy in Stage III Cervical Cancer Patients Treated with Concurrent Chemoradiation: A Multicenter Study Oncology Research and Treatment, 45(5), 254-261., Doi: 10.1159/000521980 (Publication No: 7571177) (2022) ATÇI MUHAMMED MUSTAFA, AKAGÜNDÜZ BARAN, DEMİR METİN, DÖNMEZ YILMAZ BİNNUR, AKIN TELLİ TUĞBA, CAN ORÇUN, ÇİL İBRAHİM, GÖKTAŞ AYDIN SABİN, ÖZYURT NES
- Nivolumab in metastatic renal cell carcinoma: results from the Turkish Oncology Group Kidney Cancer Consortium database. Future Oncology, 17(35), 4861-4869., Doi: 10.2217/fon-2021-0717 (Publication No: 7506054) (2021) YEKEDÜZ EMRE, ERTÜRK İSMAİL, TURAL DENİZ, KARADURMUŞ NURİ, KARAKAYA SERDAR, HIZAL MUTLU, ARIKAN RUKİYE, ARSLAN ÇAĞATAY, TABAN HAKAN, KÜÇÜKARDA AHME
- Survival and Prognostic Factors in Limited-stage Small-cell Lung Cancer. JCPSP-Journal of The College of Physicians and Surgeons Pakistan, 31(12), 1433-1437., Doi: 10.29271/jcpsp.2021.12.1433 (Publication No: 8215561) (2021) ATCI MUHAMMED MUSTAFA, SAKİN ABDULLAH, UYSAL EMRE, AKSARAY FERDİ, SELVİ OĞUZHAN, CAN ORÇUN
Good to Know
Frequently Asked Questions
What is Dr. Orçun Can's specialty?
Dr. Orçun Can is a specialist in Medical Oncology at Acibadem. For a personalised assessment, the Acibadem international patient team can review your medical history and reports and explain the suitable next steps.
Which hospital does Dr. Orçun Can practise at?
Dr. Orçun Can sees patients at in . The international patient team can confirm current availability and help you plan a consultation or visit.
What languages can I use when consulting Dr. Orçun Can?
Consultations with Dr. Orçun Can are supported in Turkish and English. In addition, Acibadem provides multilingual coordination and interpreter support so international patients can communicate clearly throughout their care.
How can I book an appointment with Dr. Orçun Can?
You can request an appointment with Dr. Orçun Can using the appointment form on this page, or by contacting the Acibadem international patient team by phone or WhatsApp. After you share your details, the team checks availability and confirms your appointment, usually within 24 hours.
Is an online video consultation available with Dr. Orçun Can?
Yes. Dr. Orçun Can offers online video consultations, so you can discuss your condition and reports with the specialist before making any travel arrangements. The international patient team can help you schedule a secure video visit.
How many years of experience does Dr. Orçun Can have?
Dr. Orçun Can has around 17 years of professional experience in Medical Oncology. A summary of education, experience and professional memberships is available on this page.
Can international patients arrange treatment with Dr. Orçun Can?
Yes. Acibadem supports international patients end to end — from the first consultation and treatment planning through appointment scheduling, interpretation during the stay and follow-up after returning home. Sharing your case for an initial assessment is free of charge.
How do I get a second opinion involving Dr. Orçun Can?
You can request an independent review of your diagnosis and proposed treatment. Share your medical reports through the consultation or "Ask a Doctor" form on this site, and the team will arrange a specialist review and explain the available options.
Care without borders
A dedicated team, from first message to follow-up
Our international patient office coordinates your appointment, travel and treatment at JCI-accredited Acıbadem hospitals — and stays with you in your own language, every step of the way.
Book an Appointment
Schedule your appointment with Dr. Orçun Can
Choose a date and time that suits you. Our international patient team will check availability and confirm your appointment — usually within 24 hours.
- 1Choose your date & timePick a preferred day and time slot for your visit.
- 2Share your detailsTell us how to reach you and anything we should know.
- 3We confirm with youOur team confirms the appointment by phone or email.
35+Years of expertise
90+Countries served
20+Languages spoken
24/7Patient support
Prefer to talk now?
Appointment Request
Request your appointment
This request goes directly to this doctor’s schedule.
Your information stays strictly confidential and is used only to arrange your care.
Departments
Medical Units
Treatments